Key Drivers
- Strong Cash Flow
- High Leverage
- Weak Liquidity
AIAI Summary
CLX is now an execution-and-balance-sheet recovery trade, not a defensive income compounder: investors should wait for clear evidence that ERP normalization, margin recovery, and GOJO synergies restore free cash flow enough to support its dividend and ~4.8x leverage, as acquisition-led sales growth alone does not provide a sufficient cushion.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Flow
- •High Leverage
- •Weak Liquidity
CLX delivers solid profitability and cash flow, but high leverage, weak liquidity, acquisition-driven debt, and an elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Persistent lower lows
- •Oversold momentum
- •Resistance unbroken
CLX is in a strong last-month downtrend to $83.10, with oversold momentum allowing a bounce but bearish control persisting unless price reclaims $85–$89 resistance.
Sharp 22% decline from roughly $106.00 since late
Sentiment & News
Key News Insights:
- •GOJO acquisition
- •Margin pressure
- •High leverage
Clorox offers strategic upside from GOJO and cost initiatives, but leverage, margin pressure, weak demand, and valuation risks warrant caution.
Near-term investor sentiment may remain constrained until Clorox demonstrates stronger organic growth and deleveraging progress
Similar Companies in Consumer Defensive
Other companies in the same sector with AI ratings